Journal of Nanomedicine & Nanotechnology

Abstract

Advancements and Utilization of Smart Nanomedicine in Urinary Tract Tumors

Alberto Dalton*

Urinary tract tumors present significant challenges in diagnosis and treatment, necessitating innovative approaches to improve therapeutic outcomes while minimizing side effects. Smart nanomedicine, with its targeted drug delivery and controlled release capabilities, has emerged as a promising solution for addressing these challenges. This review explores the advancements and utilization of smart nanomedicine in the context of urinary tract tumors. Diagnostic applications include targeted imaging, biosensors, and theranostic platforms, enabling early detection and personalized treatment planning. Therapeutic applications encompass targeted drug delivery, enhanced penetration, combination therapy, and stimuli-responsive release, offering improved efficacy and reduced toxicity. However, clinical translation faces challenges such as biocompatibility, formulation optimization, scalability, and clinical validation. Despite these challenges, smart nanomedicine holds great promise for revolutionizing the diagnosis and treatment of urinary tract tumors, paving the way for personalized and precision medicine approaches in oncology.

Published Date: 2024-05-31; Received Date: 2024-05-01